NASDAQ:ZYME - Nasdaq - US98985Y1082 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 62.20M | 76.01M | 412.50M | 26.70M | 39.00M | |||
Operating Expenses | 183.23M | 214.06M | 282.00M | 242.30M | 226.40M | |||
Research and Development | 123.08M | 143.72M | 208.60M | N/A | N/A | |||
Selling, General, and Administrative Expenses | 60.14M | 70.45M | 73.40M | 42.60M | 57.90M | |||
Operating Income | -121.03M | -138.05M | 130.50M | -215.60M | -187.50M | |||
Interest Income/Expense | 20.53M | 18.52M | 4.70M | 3.20M | 7.40M | |||
Other Income/Expense | -243.00K | 291.00K | 0.00 | 100.00K | 0.00 | |||
Non Recurring Items | N/A | N/A | N/A | 0.00 | 0.00 | |||
Income Before Taxes | -118.02M | -119.24M | 135.20M | -212.40M | -180.10M | |||
Income Tax | -4.35M | -568.00K | 10.90M | -500.00K | 400.00K | |||
Net Income | -113.67M | -118.67M | 124.30M | -211.80M | -180.60M | |||
EBITDA | -113.08M | -127.89M | 137.70M | -209.10M | -179.90M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.51 | -1.72 | 1.91 | -4.11 | -3.58 | |||
Non GAAP EPS | -1.28 | -1.73 | 1.93 | -4.11 | -3.58 | |||
Statistics | ||||||||
Profit Margin | -182.75% | -156.13% | 30.13% | -793.26% | -463.08% | |||
Operating Profit Margin | -194.58% | -181.62% | 31.64% | -807.49% | -480.77% |
All data in USD